
SerenQ Cagrilintide is a pre-filled research peptide pen containing 15 mg of cagrilintide, a long-acting amylin analogue being investigated in metabolic and weight-management research.
Back in stock alert
Leave your email and we'll let you know the moment it returns — no account needed.
Third-Party Tested
Independently verified by accredited lab
Batch Verified
Purity & potency tested every production run
Certificate of Analysis
Full documentation available on request
SerenQ Cagrilintide is a pre-filled research peptide pen containing 15 mg of cagrilintide, a long-acting amylin analogue being investigated in metabolic and weight-management research.
Cagrilintide is designed to replicate key aspects of naturally occurring amylin signalling. Research has focused on pathways involved in satiety, appetite regulation and gastric emptying, as well as its potential effects when combined with GLP-1 receptor agonists.
Cagrilintide has progressed through human clinical studies and remains under investigation. It is not currently approved as a standalone medicinal product. SerenQ Cagrilintide is supplied as a research-grade material and is not an authorised prescription medicine.
Products are supplied in sealed retail cartons with an individual serial number and QR authenticity code for product and batch verification.
Form: Pre-filled pen
15 mg of cagrilintide per pen
Supplied pre-dissolved in a liquid solution
300 graduated units in total
50 mcg per unit
Graduated dial and viewing window
Individual serial number and QR authenticity code
Sealed pre-filled pen format
3 ml total fill volume
5 mg/ml cagrilintide concentration
No separate reconstitution components supplied
4 individually sealed 32G 0.23 × 4 mm pen tips supplied
Protective cap and rigid retail carton included
Batch number, expiry date and serial number printed directly on the pen
Individual QR authenticity code for product and batch verification
Store refrigerated at 2–8°C
Do not freeze
Keep protected from direct light
Keep in the original outer carton
Solution should remain clear and free from visible particles
Keep out of reach of children and animals
Expiry on current sealed stock: 12/2027
Each SerenQ batch is submitted for independent laboratory analysis. For this batch, purity and identity testing is being conducted by Analiza using HPLC/MS methodology, with results currently pending.
The certificate of analysis will be made available once the laboratory report has been released.
Every SerenQ pen carries a unique serial number and QR authenticity code. The code can be scanned to verify the product and access available batch information and testing documentation.
1 × SerenQ Cagrilintide 15mg pre-filled research pen
4 × individually sealed 32G 0.23 × 4 mm pen tips
1 × serialised, QR-coded retail carton
Important: Cagrilintide remains an investigational compound. SerenQ Cagrilintide is not an approved medicinal product and is supplied strictly as a research-grade material.